| | |
Recent
Events for
Biotechnology
|
|
Date
|
Company
|
Event
| |
05/03/13
|
AVEO
|
AVEO Pharmaceuticals, Inc. downgraded by Canaccord Genuity
| |
05/03/13
|
AVEO
|
AVEO Pharmaceuticals, Inc. upgraded by Stifel
| |
05/03/13
|
AVEO
|
AVEO Pharmaceuticals, Inc. downgraded by RBC Capital Mkts
| |
05/03/13
|
SGMO
|
Sangamo BioSciences, Inc. coverage initiated by BioLogic Equity Research
| |
05/02/13
|
ACOR
|
Acorda Therapeutics, Inc. downgraded by MKM Partners
| |
05/01/13
|
TTNP
|
TITAN PHARMA INC downgraded by Burrill Institutional Research
| |
04/24/13
|
NPSP
|
NPS Pharmaceuticals, Inc. coverage initiated by Oppenheimer
| |
04/22/13
|
SRPT
|
Sarepta Therapeutics, Inc. coverage initiated by Needham
| |
04/19/13
|
VRTX
|
Vertex Pharmaceuticals Incorpor upgraded by Canaccord Genuity
| |
04/15/13
|
OMER
|
Omeros Corporation coverage initiated by MLV & Co
| |
04/10/13
|
VRTX
|
Vertex Pharmaceuticals Incorpor coverage initiated by Chardan Capital Markets
| |
04/09/13
|
BCRX
|
BioCryst Pharmaceuticals, Inc. upgraded by MLV & Co
| |
04/05/13
|
CELG
|
Celgene Corporation upgraded by Deutsche Bank
| |
04/05/13
|
GTXI
|
GTx, Inc. coverage initiated by Stifel
| |
04/04/13
|
SRPT
|
Sarepta Therapeutics, Inc. coverage initiated by Robert W. Baird
| |
04/03/13
|
SRPT
|
Sarepta Therapeutics, Inc. coverage initiated by Robert W. Baird
| |
03/28/13
|
ASTM
|
Aastrom Biosciences, Inc. downgraded by Ascendiant Capital Markets
| |
03/27/13
|
ASTM
|
Aastrom Biosciences, Inc. downgraded by Needham
| |
03/25/13
|
CELG
|
Celgene Corporation downgraded by WallachBeth
| |
03/25/13
|
GALE
|
Galena Biopharma, Inc. coverage initiated by Needham
|
| |
| |
More Recent Events...
|
| |
|